SEC Form 5 · accession 0001547522-16-000213
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Jeremy M Jones
Director
Period of report
Dec 31, 2015
Accepted (ET)
Feb 16, 2016 · 5:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Feb 15, 2016 | J | 50,000 | $0.185 | A | 182,474 | I | Held by Jones Family Trust |
| Common stock | holding | — | — | — | 132,474 | I | Held by Jones Family Trust | |
| Common stock | holding | — | — | — | 181,818 | I | Held by Jones Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Acquired as an incentive for extending the due date of certain payment obligations by the Company.